Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

Clinical trial NCT01303705 · COMPLETED

Trial details

NCT number: NCT01303705
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Cancer of the Prostate Prostate Cancer

Start date: 2010-10-14
Primary completion: 2016-07-05
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.